Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

JNK: a new therapeutic target for diabetes

2 Jun 2003

Abstract excerpt

No abstract is available from the source.

Topics

Join the communities discussing this publication.

Adipokines, Inflammation, and Metabolic Diseases
Adipose Tissue and Metabolism
Natural Antidiabetic Agents Studies

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 12901952
DOI: 10.1016/s1471-4892(03)00068-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

JNK: a new therapeutic target for diabetesPMID 12901952Read ↗

From JNK to Pay Dirt: Jun Kinases, their Biochemistry, Physiology and Clinical ImportanceSemantic proximity Read ↗

JNK and cardiometabolic dysfunctionSemantic proximity Read ↗

The isoform‐specific functions of the c‐Jun N‐terminal Kinases (JNKs): differences revealed by gene targetingSemantic proximity Read ↗

JNK1, a potential therapeutic target for hepatocellular carcinomaSemantic proximity Read ↗

Progress toward molecular therapy for diabetes mellitus: A focus on targeting inflammatory factorsSemantic proximity Read ↗

Wiring the cell signaling circuitry by the NF-κB and JNK1 crosstalk and its applications in human diseasesSemantic proximity Read ↗

c-Jun N-Terminal Kinase Inhibitors as Potential Leads for New Therapeutics for Alzheimer’s DiseasesSemantic proximity Read ↗

c-Jun N-terminal kinase signaling in agingSemantic proximity Read ↗

JNK3 Perpetuates Metabolic Stress Induced by Aβ PeptidesSemantic proximity Read ↗

Disruption of the Jnk2 (Mapk9) gene reduces destructive insulitis and diabetes in a mouse model of type I diabetes.Semantic proximity Read ↗

Non-kinase targeting of oncogenic c-Jun N-terminal kinase (JNK) signaling: the future of clinically viable cancer treatmentsSemantic proximity Read ↗

ROS constitute a convergence nexus in the development of IGF1 resistance and impaired wound healing in a rat model of type 2 diabetes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.